Skip to main content

#156610

Anti-CD53 [OX44]

Cat. #156610

Anti-CD53 [OX44]

Cat. #: 156610

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD53

Class: Monoclonal

Application: FACS ; IHC ; IP

Reactivity: Rat

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Medical Research Council; University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD53 [OX44]
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Rat
  • Host: Mouse
  • Application: FACS ; IHC ; IP
  • Description: The antibody is directed against rat CD53 and labels mature T and B cells but only 13% of thymocytes. OX-44 positive cells in the thymus include cells at all stages of differentiation to immunocompetent T cells.
  • Immunogen: T lymphocytes from a mixed lymphocyte reaction between purified rat T helper cells and irradiated semiallogeneic rat spleen
  • Myeloma used: NS0/1
  • Recommended controls: IgG1

Target Details

  • Target: CD53
  • Target background: The antibody is directed against rat CD53 and labels mature T and B cells but only 13% of thymocytes. OX-44 positive cells in the thymus include cells at all stages of differentiation to immunocompetent T cells.

Applications

  • Application: FACS ; IHC ; IP

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Bellacosa et al. 1991. Mol Cell Biol. 11(5):2864-72. PMID: 2017181.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.